In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 36 for your search:
Drug:  fenretinide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: postmenopausal
Sponsor: NCI
Protocol IDs: E-EB193, CLB-9443, NCCTG-953052, SWOG-9514, INT-0151, NCT00002646

2.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID92-027, P30CA016672, MDA-ID-92027, NCI-P97-0092, CDR0000065761, NCT00003075

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067387, MDA-ID-95236, NCI-G99-1621, NCI-T98-0051, ID95-236, T98-0051, NCT00004154

4.

Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: 50-84
Sponsor: NCI
Protocol IDs: MDA-ID-95184, NCI-P97-0099

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: ICC-88B3, NCI-T89-0087D, T89-0087

6.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9460, NCI-P96-0074

7.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-93018, NCI-P97-0079

8.

Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: MSGCC-9224, NCI-P97-0098

9.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: UAB-9431, NCI-P97-0103

10.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor: NCI
Protocol IDs: BCM-H2533, NCI-P97-0107

11.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: ID94-029, P30CA016672, MDA-ID-94029, NCI-P97-0113, CDR0000065829, NCT00003099

12.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 45 and over
Sponsor: NCI
Protocol IDs: MSGCC-9215, NCI-P97-0114

13.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066674, E-2695, UPCC-2600, NCI-P98-0134, NCT00003601

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067401, UAB-9713, NCI-G99-1626, NCT00004161

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068068, NABTC-9905, UCLA-0006094, NCT00006080

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID99-334, U01CA070172, P30CA016672, MDA-ID-99334, NCI-610, CDR0000068294, 610, NCT00006471

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068428, CCUM-9940, NCI-T99-0112, T99-0112, NCT00009971

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068465, U01CA062487, P30CA022453, WSU-C-2232, NCI-WSU-910, NCT00011973

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00457, PHII-25, N01CM17101, CDR0000068985, CCC-PHII-25, LAC-USC-5GYN003, NCI-19, 19, NCT00026091

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0231D, NCI-MB-299, NCI-T92-0082N, T92-0082

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-92037, NCI-T92-0113C, T92-0113

22.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: WSU-C-1001, NCI-P93-0035

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under at original diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01802, COG-ADVL0024, COG-A0996, CDR0000269408, COG-ANBL0321, ADVL0024, ANBL0321, U10CA098543, NCT00053326

24.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: CNR-IEO-007, U01-CA77188-01

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: CTRG-P18/02, NCI-6062, NCT00077402, 6062
1   
New Search